Q3 2025 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2025-11-14 · accession 0001172661-25-004839
$1.48B
Reported value
76
Positions
2025-09-30
Period end
The Brief · Integral Health Asset Management, LLC · Q3 2025
AI · grounded in 13F
Integral Health Asset Management, LLC established a new position in INSM valued at $244.8M. The fund also initiated new stakes in CYTK for $118.2M and THC for $60.9M. Other new additions include MLYS at $56.9M and VERA at $49.4M. The fund ended the period with 74 positions and total AUM of $1.48B.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $230.4M | 15.6% | 1,600,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $76.9M | 5.21% | 1,400,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $60.9M | 4.12% | 300,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $56.9M | 3.85% | 1,500,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $49.4M | 3.34% | 1,700,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $41.2M | 2.79% | 750,000 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $35.0M | 2.37% | 600,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $34.0M | 2.30% | 1,150,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $29.3M | 1.98% | 300,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $28.4M | 1.92% | 1,000,000 | PUT | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $28.1M | 1.90% | 50,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $27.9M | 1.89% | 1,600,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $27.4M | 1.85% | 60,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $25.6M | 1.74% | 200,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $25.4M | 1.72% | 200,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $24.3M | 1.65% | 1,500,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $23.0M | 1.56% | 300,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $22.9M | 1.55% | 300,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $22.2M | 1.50% | 220,000 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $22.2M | 1.50% | 400,000 | PUT | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $21.1M | 1.42% | 150,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $20.4M | 1.38% | 130,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $18.8M | 1.27% | 2,000,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $18.7M | 1.26% | 400,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $16.2M | 1.10% | 85,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $16.2M | 1.09% | 50,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $16.1M | 1.09% | 800,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $15.6M | 1.05% | 200,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $15.3M | 1.03% | 20,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $15.1M | 1.02% | 200,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $14.9M | 1.01% | 250,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $14.4M | 0.97% | 100,000 | PUT | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $14.3M | 0.97% | 150,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $14.3M | 0.97% | 400,000 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $13.2M | 0.89% | 180,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $12.7M | 0.86% | 500,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $12.7M | 0.86% | 50,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $12.3M | 0.83% | 150,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $11.9M | 0.81% | 60,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $11.8M | 0.80% | 450,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $11.6M | 0.78% | 15,000 | Common | SOLE |
| 00846U101 | A | AGILENT TECHNOLOGIES INC | $11.6M | 0.78% | 90,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $11.3M | 0.77% | 750,000 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $11.2M | 0.76% | 550,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $11.2M | 0.76% | 25,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $11.2M | 0.76% | 65,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $10.9M | 0.74% | 200,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $10.8M | 0.73% | 575,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $10.8M | 0.73% | 900,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $10.6M | 0.72% | 1,100,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $10.4M | 0.70% | 550,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $10.1M | 0.68% | 800,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $9.8M | 0.66% | 650,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $9.7M | 0.66% | 400,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $9.4M | 0.64% | 60,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $8.9M | 0.60% | 120,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $8.5M | 0.58% | 45,000 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $8.3M | 0.56% | 1,500,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $8.2M | 0.55% | 100,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $7.8M | 0.53% | 225,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $7.4M | 0.50% | 300,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $7.1M | 0.48% | 950,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $7.1M | 0.48% | 2,000,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $6.7M | 0.46% | 100,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $6.5M | 0.44% | 95,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $6.1M | 0.41% | 1,400,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $5.9M | 0.40% | 150,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $5.7M | 0.38% | 250,000 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $5.6M | 0.38% | 30,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $5.0M | 0.34% | 200,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $4.0M | 0.27% | 1,500,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.7M | 0.25% | 100,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.2M | 0.22% | 350,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1.6M | 0.11% | 400,000 | Common | SOLE |
| 50180M108 | LBRX | LB PHARMACEUTICALS INC | $1.6M | 0.11% | 100,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $1.3M | 0.09% | 167,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.